Clarivate Plc reports developments in data, analytics and workflow software for academia and government, intellectual property, and life sciences and healthcare. Its news commonly covers earnings, subscription and recurring revenue trends, cash flow and leverage actions, and progress under its operating improvement initiatives.
Company updates also focus on AI-enabled research and decision-support products, including Web of Science Research Intelligence, Nexus Connect, Cortellis Regulatory Intelligence, Derwent-based patent analytics and other Clarivate data assets. Recurring announcements address institutional research intelligence, academic library workflows, regulatory intelligence for life sciences teams, intellectual property benchmarks and investor conference appearances.
Clarivate Plc (NYSE:CLVT) has unveiled a comprehensive framework for evaluating the societal impact of research. The approach, detailed in a new report by the Institute for Scientific Information (ISI)™, addresses the growing demand for demonstrating the benefits of R&D investments across various sectors of society.
The framework categorizes societal needs into eight facets: Political & Policy, Legal & Governance, Economic, Human Capital, Medical, Social & Cultural, Technological and Environmental. It aims to balance qualitative and quantitative approaches, extending beyond traditional quantitative indicators.
To address the challenge of long timeframes between research discovery and societal application, the framework incorporates both lagging and leading indicators. This new approach will be integrated into the upcoming Web of Science Research Intelligence™ platform.
Clarivate Plc (NYSE: CLVT) has released a new report titled 'Excellence in IP Operations' based on a global survey of 184 IP professionals. The report highlights key challenges and trends shaping intellectual property (IP) operations, focusing on strategy alignment, resource allocation, technology enablement, and AI adoption.
Key findings include:
- 65% of corporate respondents with clear KPIs reported alignment between IP and business strategies
- Well-managed operational processes correlate with greater strategic alignment and efficient staff use
- 83% of respondents spending over half their time on unrelated tasks were not using AI in their IP department
- 64% of respondents dissatisfied with their technology setup spent more time on tasks outside their primary role
The report emphasizes the importance of aligning KPIs with business goals, effective process management, closing the AI adoption gap, and leveraging technology for efficiency in IP operations.
Clarivate Plc (NYSE: CLVT) has announced a strategic partnership with Relatable Healthcare to enhance medtech sales contracting processes. This collaboration integrates Clarivate's comprehensive competitive intelligence into Relatable's Product Relationship Management (PRM) platform, providing medtech companies with a single source of truth for product information and competitive data.
The partnership aims to empower clients to make informed pricing decisions, streamline sales contracting, and improve contract compliance. It addresses the challenges faced by medical device and supply companies in communicating product value and offering consultative insights in a cost-constrained healthcare environment.
By combining Clarivate's deep product-level market knowledge with Relatable Healthcare's enterprise software, the partnership equips medtech companies with tools to win new business and drive contract compliance more efficiently, particularly when serving Integrated Delivery Networks (IDNs), Group Purchasing Organizations (GPOs), and various healthcare providers.
Clarivate Plc (NYSE:CLVT) has unveiled its Citation Laureates™ 2024 list, recognizing 22 exceptional scientists and economists from six countries whose work is considered of Nobel stature. These individuals have made significant contributions in areas such as clean energy, nanotechnology, 3D protein structures, and quantum computing. The list includes 11 researchers from the US, six from the UK, two from Switzerland, and one each from Germany, Israel, and Japan.
Clarivate's Institute for Scientific Information (ISI)™ has successfully identified 75 Citation Laureates prior to their Nobel success. The selection process is based on publication and citation data from the Web of Science™, focusing on authors whose papers have been cited more than 2,000 times. This year's laureates span fields including Physiology or Medicine, Physics, Chemistry, and Economics.
Clarivate Plc (NYSE:CLVT) has announced the full agenda for the 15th annual Clarivate Pharmavision India conference, scheduled for September 25-26, 2024, in Ahmedabad and Hyderabad. The event focuses on improving patient outcomes and building resilience in the healthcare ecosystem. Key topics include AI in healthcare, cell and gene therapy, and market access.
The conference aims to address challenges such as healthcare affordability and access in India. Industry leaders will discuss strategies for patient-centric innovation, R&D, generics, biosimilars, and healthcare manufacturing. Notable sessions will cover topics like balancing generics and innovation, AI's role in healthcare, and addressing barriers to cell and gene therapy integration in India.
Clarivate Plc (NYSE:CLVT) has launched Primo™ Research Assistant, a generative AI-powered library discovery solution. Developed in collaboration with library partners, it offers students and researchers a seamless experience with natural language queries and immediate answers grounded in trusted sources. Key features include:
- Semantic search and natural language queries
- AI-powered answers with source references
- Search suggestions for topic expansion
- Multi-language support
The solution is built on a Retrieval Augmented Generation (RAG) architecture and utilizes the Ex Libris Central Discovery Index (CDI), containing over 5 billion records. The beta program, which began in June 2024, involved 18 institutions across 10 countries. Clarivate aims to responsibly apply AI in academia, fostering trust and innovation in research.
Clarivate Plc (NYSE:CLVT) has released its first Pulse of the Library™ report, revealing insights on Artificial Intelligence (AI) implementation in libraries. The report, based on a survey of over 1,500 librarians worldwide, shows that:
- Over 60% of libraries are evaluating or planning for AI integration
- 43% prioritize AI-powered tools for users in the next 12 months
- Key AI goals include supporting student learning (52%), research excellence (47%), and content discoverability (45%)
- 42% believe AI can automate routine tasks, freeing librarians for strategic activities
- Challenges include shrinking budgets (47%) and lack of AI expertise (32% report no training available)
The report highlights regional differences in priorities and emphasizes the need for collaboration between IT experts and senior leadership to advance AI implementation in libraries.
Clarivate Plc (NYSE: CLVT), a global leader in transformative intelligence, has announced its participation in the upcoming Goldman Sachs Communacopia + Technology Conference. Jonathan Collins, Executive Vice President and Chief Financial Officer, will represent the company at the event on Thursday, September 12, 2024, at 8:50 am Pacific Time (11:50 am Eastern Time).
Interested parties can access the live webcast of the presentation through a provided link. For those unable to attend in real-time, a replay will be available on the same platform. Additionally, the presentation will be archived on Clarivate's investor relations website for 180 days, ensuring extended access for stakeholders and interested investors.
Clarivate Plc (NYSE:CLVT) has launched the Web of Science™ Research Assistant, a generative AI-powered tool designed to enhance research efficiency. Developed in partnership with the research community, this tool leverages the Web of Science Core Collection™ to help researchers:
- Find key papers faster
- Handle complex research tasks
- Visualize connections in research fields
The Research Assistant offers flexible document searches, guided prompts, and unique data visualizations. It entered beta testing in December 2023 and was created in collaboration with librarians and researchers worldwide to ensure high standards of quality, accuracy, and privacy.
Clarivate (NYSE: CLVT), a global provider of transformative intelligence, has appointed Melanie Margolin to the expanded role of Chief Administrative and Legal Officer.
Joining the company in September 2023 as Executive Vice President and Chief Legal Officer, Margolin will now oversee human resources, facilities, communications, and brand functions, in addition to global legal affairs, risk, sustainability, privacy, and compliance.
CEO Matti Shem Tov commended Margolin for her strategic insights and emphasis on talent development, reflecting her people-centric leadership style. Margolin expressed her commitment to fostering collaboration and growth at Clarivate.